DiaDexus Funds Michigan s Hanash in Biomarker Research Deal | GenomeWeb

NEW YORK, Sept. 4-DiaDexus will support University of Michigan geneticist Samir Hanash in research using proteomic techniques to develop new biomarkers to diagnose and treat cancer, the company said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.